Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM, A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function, «CANCER RESEARCH», 2011, 71, pp. 6220 - 6229 [Scientific article]
C. Garofalo; M. C. Manara; G. Nicoletti; M.T. Marino; P.-L. Lollini; A. Astolfi; G. Pandini; J.A. López-Guerrero; K.L. Schaefer; A. Belfiore; P. Picci; K. Scotlandi., Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling., «ONCOGENE», 2011, 30, pp. 2730 - 2740 [Scientific article]
Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; Parmiani G; NIBIT [..; P.L. Lollini; ..], Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010., «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2011, 60, pp. 901 - 907 [Scientific article]
L.Landuzzi; A. Antognoli; G. Nicoletti; S. Croci; A. Palladini; ML. Ianzano; A. Murgo; V. Stivani; V. Grosso; P. Nanni; C. De Giovanni; P. Lollini, HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines, «VACCINE», 2011, 29, pp. 4690 - 4697 [Scientific article]
P.-L. Lollini; P. Nanni; C. De Giovanni., Immunotherapy, in: Cancer metastasis: Biologic basis and therapeutics, CAMBRIDGE, Cambridge University Press, 2011, pp. 583 - 595 [Chapter or essay]
Patent n. U.S. Serial No- 61/530,089, filed September 1, 2011., Methods of treating bone cancer.
E. Bolli; E. Quaglino; M. Arigoni; P.-L. Lollini; R. Calogero; G. Forni; F. Cavallo, Oncoantigens for an immune prevention of cancer, «AMERICAN JOURNAL OF CANCER RESEARCH», 2011, 1, pp. 255 - 264 [Scientific article]
G. Campadelli-Fiume; C. De Giovanni; V. Gatta; P. Nanni; P.L. Lollini; L. Menotti, Rethinking herpes simplex virus: the way to oncolytic agents., «REVIEWS IN MEDICAL VIROLOGY», 2011, 21, pp. 213 - 226 [Scientific article]
M. Pasello; M.C. Manara; F. Michelacci; M. Fanelli; C.M. Hattinger; G. Nicoletti; L. Landuzzi; P.-L. Lollini; A. Caccuri; P. Picci; K. Scotlandi; M. Serra., Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy., «ANALYTICAL CELLULAR PATHOLOGY», 2011, 34, pp. 131 - 145 [Scientific article]Open Access
T. Mueck; F. Berger; I. Buechsler; R.S. Valchanova; L. Landuzzi; P.-L. Lollini; K. Klingel; B. Munz, TRAF6 regulates proliferation and differentiation of skeletal myoblasts, «DIFFERENTIATION», 2011, 81, pp. 99 - 106 [Scientific article]
P. Lollini; G. Nicoletti; L. Landuzzi; F. Cavallo; G. Forni; C. De Giovanni; P. Nanni, Vaccines and other immunological approaches for cancer immunoprevention, «CURRENT DRUG TARGETS», 2011, 12, pp. 1957 - 1973 [Scientific article]
G. Forni; P.-L. Lollini, Vaccini antitumorali, in: Supplemento 2011 de La Piccola Treccani, ROMA, Istituto della Enciclopedia Italiana Treccani, 2011, pp. 1 - 1 [Dictionary or encyclopedia entry]
F. Cavallo; C. De Giovanni; P. Nanni; G. Forni; P. Lollini, 2011: the immune hallmarks of cancer, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2011, 60, pp. 319 - 326 [Scientific article]
E. Quaglino; C. Mastini; A. Amici; C. Marchini; M. Iezzi; S. Lanzardo; C. De Giovanni; M. Montani; P.-L. Lollini; G. Masucci; G. Forni; F. Cavallo, A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins, «CANCER RESEARCH», 2010, 70, pp. 2604 - 2612 [Scientific article]
F. Pappalardo; M.-P. Lefranc; P.-L. Lollini; S. Motta, A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY, «IMMUNOME RESEARCH», 2010, 64, pp. 1 - 14 [Scientific article]
